Stanley F. Nelson, MD is Professor and Vice Chair of Human Genetics and Professor of Psychiatry within the David Geffen School of Medicine at UCLA where he has been on faculty since 1993. Prof. Nelson attended the University of Michigan and obtained a BS degree in Physics in 1982. He graduated from Duke University School of Medicine in 1987 and completed an ITT International Fellowship to Sweden in the Laboratory of George Klein. He was trained in Pediatrics and Pediatric Hematology-Oncology at UCSF School of Medicine, and subsequently trained as a postdoctoral fellow with Patrick Brown from 1990-1993 where he developed genomic mismatch scanning and initiated the lab development of DNA microarrays for genomic applications. At UCLA, Prof. Nelson has continued to be interested in technology development and application of genomics to cancer biology and common human diseases with active research areas in Autism, ADHD, vertigo and brain cancers. He developed and led the first genomics core on UCLA campus ( UCLA DNA Microarray Facility). He led the whole genome expression array analysis for the NIH Neuroscience Blueprint. With a team in Pathology and Pediatrics, he implemented whole exome sequencing for clinical purposes in 2011. He formed the Center for Duchenne Muscular Dystrophy in 2007 with Drs. Miceli and Spencer that has grown into a unique center that provides coordinated patient care, access to clinical trials, translational and basic research, and educational opportunities on campus. In 2014, he initiated with others, the Undiagnosed Diseases Network UCLA Clinical Site to improve diagnosis of individuals with difficult to diagnose genetic disorders. His laboratory continues to develop and use genomic techology to pursue biological insights that lead to new therapeutic interventions in humans.
Could Desperate Parents' Pleas Sway The FDA To Approve A Drug Even If Evidence It Works Is Lacking? > Spotlight on drug for Duchenne muscular dystrophy by Forbes (April 24, 2016)
Learn more about myUCLAhealth